City of Milford Awards Incentive Agreement Contract to Meridian Bioscience (March 2024)
- Approved
- Mar 5, 2024
- Term
- 3 five-year periods
The 30-second brief
Ordinance approved authorizing the City Manager to enter into an incentive agreement with Meridian Bioscience, Inc. for conducting business within the city and creating/retaining approximately 30 full-time jobs during a three-year period.
Meridian Bioscience holds this incentive agreement contract with City of Milford. Its other public contracts on record include work for Curry General Hospital and Nor-Lea Hospital District.
Term as filed: 3 five-year periods.
See who signed off on this contract.
See who signed offFree account · 30-second setup · No credit card
Contract details
- Contract type
- Incentive Agreement
- Document date
- March 5, 2024
- Term
- 3 five-year periods
- Vendor
- Meridian Bioscience
- Agency
- City of Milford
- Source document
- city-of-milford-council-meeting-minutes-march-5-2024_e03.pdf (Minutes)
Meridian Bioscience's other public contracts
More City of Milford contracts
Questions about this contract
Who was awarded the incentive agreement contract by City of Milford?
Meridian Bioscience was awarded this incentive agreement contract by City of Milford, as recorded on March 5, 2024.
What type of contract is this?
This is a Incentive Agreement contract, documented as a minutes record.
Where was this contract approved?
This contract appears in city-of-milford-council-meeting-minutes-march-5-2024_e03.pdf (Minutes), dated March 5, 2024 from City of Milford. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Meridian Bioscience hold?
Meridian Bioscience may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is City of Milford currently buying?
Explore City of Milford's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.